Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to -$0.07.

  • Ultralife's EPS (Weighted Average and Diluted) fell 45000.0% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year decrease of 9777.78%. This contributed to the annual value of $0.38 for FY2024, which is 1344.95% down from last year.
  • Latest data reveals that Ultralife reported EPS (Weighted Average and Diluted) of -$0.07 as of Q3 2025, which was down 45000.0% from $0.05 recorded in Q2 2025.
  • In the past 5 years, Ultralife's EPS (Weighted Average and Diluted) ranged from a high of $0.18 in Q2 2024 and a low of -$0.07 during Q3 2025
  • Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was $0.04 (2021), whereas its average is $0.05.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 50000.0% in 2024, then plummeted by 45000.0% in 2025.
  • Ultralife's EPS (Weighted Average and Diluted) (Quarter) stood at $0.05 in 2021, then skyrocketed by 247.44% to $0.18 in 2023, then tumbled by 92.09% to $0.01 in 2024, then crashed by 603.73% to -$0.07 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.07 for Q3 2025, versus $0.05 for Q2 2025 and $0.02 for Q1 2025.